The Spectranetics Corporation

SPNC develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are sold in over 65 countries and are used to treat arterial blockages in the heart and legs and in the removal of pacemaker and defibrillator leads. The Company’s Vascular Intervention (VI) products include a range of laser catheters for ablation of blockages in arteries above and below the knee, the AngioSculpt® scoring balloon used in both peripheral and coronary procedures and Stellarex™ drug-coated balloon peripheral angioplasty platform, which received European CE mark approval in December 2014. The Company also markets support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions. The Company markets aspiration and cardiac laser catheters to treat blockages in the heart. The Lead Management (LM) product line includes excimer laser sheaths, dilator sheaths, mechanical sheaths and accessories for the removal of pacemaker and defibrillator cardiac leads.
Type
Public
HQ
Colorado Springs, US
Founded
1984
Employees
892 (est)
The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, US

The Spectranetics Corporation Locations

Colorado Springs, US

The Spectranetics Corporation Metrics

The Spectranetics Corporation Summary

Market capitalization

$988 M

Closing share price

$22.3
The Spectranetics Corporation's latest market capitalization is $988 M.

The Spectranetics Corporation Market Value History

The Spectranetics Corporation Company Life